With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Lupin and Zydus partner to co-market semaglutide in India, entering a Rs 1,200 crore market with over 20 competitors and rapidly commoditising pricing dynamics.
Paris will choose a new mayor on Sunday, with one unlikely issue dominating campaigns alongside all the partisan acrimony - dogs. Candidates from socialists to conservatives have set out policies to ...
The investigation, published by the London Assembly health committee, said it had also found evidence of personal trainers ...
ILLEGAL fake weight loss jabs are now being sold in pubs and fish and chip shops, a concerning report has revealed. The ...
Biocon earns USFDA nod for Liraglutide injection, boosting its diabetes drug portfolio. Explore investment opportunities now!
Rising Chronic Disease Burden, Biosimilar Insulin Adoption, and Smart Connected Pen Technologies Drive Sustained Market Expansion.Austin, United States, March 12, 2026 (GLOBE NEWSWIRE) -- As per SNS ...
As NAD+ injections and IV drips trend from TikTok to the Kardashians, the science of longevity remains a work in progress.
On the heels of its debut as a public company, Medtronic’s former diabetes division MiniMed has claimed a European approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results